Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4B | P0C869 | 6/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | TLR2 | O60603 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | BHMT | Q93088 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14865721 | 0.85 | PLA2G4B (0.41) | PLA2G4BHSD17B10TDP1CYP1A2CYP3A4 | |
| SCHEMBL14865764 | 0.84 | HSD17B10 (0.41) | PLA2G4BHSD17B10TDP1CYP1A2CYP3A4 | |
| SCHEMBL10316173 | 0.83 | PLA2G4B (0.50) | PLA2G4BHSD17B10TDP1LMNAKMT2A | |
| SCHEMBL14865730 | 0.81 | PLA2G4B (0.50) | PLA2G4BLMNAKMT2ACYP1A2CYP3A4 | |
| SCHEMBL14865723 | 0.80 | HSD17B10 (0.44) | PLA2G4BHSD17B10TDP1KMT2ATSHR | |
| SCHEMBL17933338 | 0.79 | HSD17B10 (0.50) | PLA2G4BHSD17B10TDP1LMNACYP1A2 | |
| SCHEMBL14865731 | 0.78 | USP2 (0.50) | PLA2G4BHSD17B10KMT2ACYP1A2CYP3A4 | |
| SCHEMBL27513618 | 0.76 | LMNA (0.52) | PLA2G4BHSD17B10TDP1LMNAKMT2A | |
| SCHEMBL19521376 | 0.76 | BHMT (0.43) | PLA2G4BBHMT | |
| SCHEMBL19521379 | 0.76 | BHMT (0.43) | PLA2G4BBHMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8530559-B2 | Composite of organic compound and copper nanoparticles, composite of organic compound and copper(I) oxide nanoparticles, and methods for producing the composites | DIC CORPORATION (JP) | 2013-09-10 | — | — | US | disclosed |
| US-20130095320-A1 | COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES | DIC CORPORATION (JP) | 2013-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130095320-A1 | COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES | AOC3, AOC2, CORO1C | PLA2G4B 4671/4885HSD17B10 2100/4885TDP1 4011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.